Mr. Michael Vertolli: First of all, I should mention that due to the transitionary nature of what's going on, Health Canada, probably partly as a result of consultations they've had with the advisory panel and other stakeholders, has made some interim changes to the regulatory structure that have taken off some of those restrictions, at least insofar as products being eliminated from the marketplace.
M. Michael Vertolli: Compte tenu de la période de transition dans laquelle nous nous trouvons, et à l'issue sans doute des consultations avec le comité consultatif et d'autres intervenants, Santé Canada a supprimé certains produits de la liste des produits interdits.